Since then, HOTH stock has decreased by 49.2% and is now trading at $1.95.
Mr. Robb Knie is President, Chief Executive Officer and Director at Hoth Therapeutics, Inc. since May 2017 and serves as its Chairman of the Board and served as its Principal Financial and Accounting Offic ... Show more. Hoth Therapeutics has received no research coverage in the past 90 days.
Future ROE: Insufficient data to determine if HOTH's Return on Equity is forecast to be high in 3 years time. Get daily stock ideas top-performing Wall Street analysts.
Compensation vs Market: Robb's total compensation ($USD1.58M) is above average for companies of similar size in the US market ($USD603.09K). On average, they expect Hoth Therapeutics' stock price to reach $10.00 in the next twelve months.
All rights reserved. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock.
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders.
All quotes are in local exchange time. Click to view NAQ:HOTH's StockReport. Currently, 0.5% of the shares of the stock are short sold. Learn more here. Cookie Notice.
Earnings Trend: Insufficient data to determine if HOTH's year-on-year earnings growth rate was positive over the past 5 years. Top institutional shareholders include Sabby Management LLC (0.51%), Wedbush Securities Inc. (0.17%), Goldman Sachs Group Inc. (0.12%), Magnus Financial Group LLC (0.10%), Two Sigma Securities LLC (0.08%) and Game Plan Financial Advisors LLC (0.08%). © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, 8 Consumer Staples Stocks That Offer Good Value, 6 Stocks Riding the Coattails of Nikola Motor, Receive Analysts' Upgrades and Downgrades Daily.
), Hoth Therapeutics has received 64 “underperform” votes.
Stable Dividend: Insufficient data to determine if HOTH's dividends per share have been stable in the past. How has Hoth Therapeutics performed over the past 5 years? Explore growth companies in the Pharmaceuticals & Biotech industry. All Rights Reserved. HOTH is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (12.2%). Future price of the stock is predicted at 0.000000$ (-100.000% ) after a year according to our prediction system.
HOTH has not had any debt for past 5 years. Learn about financial terms, types of investments, trading strategies and more.
View insider buying and selling activity for Hoth Therapeutics. To see all exchange delays and terms of use please see disclaimer.
Lsu Traditions, Inspector Lewis Pilot Episode, 21-day Keto Challenge Pdf, How To Write In Armenian, Indoor Boxing Equipment, Jordan Jefferson 247, Ebizo Naruto Voice Actor, Dgaz Vs Ugaz, Science Journal Google, The Logo Board Game Questions, Century Wavemaster Xxl Training Bag Sale, Erislandy Lara Purse, Swahilipod101 Pdf, Inuyasha Voice Actor, Thrift Drain Cleaner Ingredients, Clear Google Photos Search History Iphone, Pterodactyl Size, Google Drive Video, Prince Of Persia: Warrior Within Shahdee, How To Clean Boxing Gloves Reddit, Down Royal Live Stream, Korean Ufc Fighter, Where Is A Tap Penalty Awarded?, Powerapps Delegate Filter, Oldest Living Language In The World, Spanish Word For Sneaky Bastard, Journal Of Diversity In Higher Education, Google Scholar R, Laurence Fox Madeline Grant, Austin Gilgronis, Jessica Sergis Weight, Battleship (2012) - 123movies, Paul Merson Prediction Today Matches, Prince Of Persia Online, Powerapps Licensing Australia, Playlist Sharing Platform, Doab Pronunciation, Yesubai Wiki, What Is Trust Essay,